“…In addition, these methods are capable of being used during the production/formulation processes for monitoring of minor structural as well as conformational variations occurred in protein structure which can lead to significant changes in biological activity of the drug [15]. Most of the chromatographic methods presented for IFN-␣2b analysis have gain limited attention in practical use because of a series of inherent problems including very long run-time [13,[16][17][18][19], the need for special columns and/or other equipments, high variations in responses and, finally, the high expertise needed for use and interpretation of the results obtained from these methods [13,[18][19][20][21][22]. Therefore, in this article we have developed and validated a simple and available gradient reversed-phase HPLC method with UV detection for quantitation of IFN-␣2b in parenteral dosage forms and delivery systems.…”